Sign Up for Free!

Continue Analyzing the page and more.

Continue with Google

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Upgrade to Pro
Home Daily Intelligence Tracker
    • Plans Blog Contact
    Glucose Health, Inc. logo
    GLUC

    Glucose Health, Inc.

    MaveScore 41 Low model confidence
    Last Price US$0.40 As of Jul 09, 2026
    Market Cap US$1.4m Company size context
    7D Performance -17.71% Past 7 days
    1Y Performance 295.00% Past 12 months
    Model Rating
    Historical model output for research review

    Fundamental data date

    Sep 30, 2017

    3206 days old

    Market price date

    Jul 09, 2026

    2 days old

    Coverage

    16/16

    No missing model inputs

    Data quality

    Review

    Partial or delayed snapshot

    Transparent research score

    Why the model scores this stock

    MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

    MaveScore 41 Low confidence

    Stored data quality

    Freshness and coverage checks

    16/16 Partial or delayed snapshot

    Quality

    12/35 Weak

    Blends latest model rank with profitability and dilution ranks.

    Financial Strength

    13/25 Mixed

    Rewards durable profitability, margins, and positive free cash flow.

    Valuation Support

    5/15 Weak

    Favors positive earnings, positive cash flow, and lower multiples.

    Momentum

    10/15 Mixed

    Highlights research candidates with supportive 3-month and 6-month price regimes.

    Shareholder Alignment

    1/10 Weak

    Rewards less dilutive share behavior and enough size for liquid research coverage.

    Positive model output

    More live company inputs are needed before positive research signals can be surfaced.

    Research risks to review

    • Blends latest model rank with profitability and dilution ranks.
    • Favors positive earnings, positive cash flow, and lower multiples.
    • Rewards less dilutive share behavior and enough size for liquid research coverage.

    MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting.

    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Glucose Health, Inc. Overview

    Industry: Packaged Foods

    Sector: Consumer Defensive

    Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas. Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. Th Read More

    Glucose Health, Inc. is evaluated based on the investment philosophy and approach to stock market investing developed by renowned investor Warren Buffett. Companies with high ratings typically exhibit growing earnings, a substantial profit margin, conservative leverage, a consistently high return on equity, and a sustained practice of repurchasing their shares over the years.

    Glucose Health, Inc.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Nov 14, 2017

    Quarterly result summary

    Latest company-filed earnings material is available for source review.

    What changed

    • Review the SEC source filing for the full reported results and management commentary.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    SEC filing Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing FORM 10-Q Aug 21, 2017 SEC filing FORM 10-Q May 15, 2017 SEC filing FORM 10-K Mar 29, 2017 SEC filing FORM 10-Q Dec 21, 2016 SEC filing FORM 10-Q Aug 22, 2016 SEC filing FORM 10-Q May 23, 2016 SEC filing FORM 10-K Apr 14, 2016

    Recent News



    Earnings Per Share

    Score 3.00/5
    Glucose Health, Inc. boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes
    In Packaged Foods industry , General Mills Inc , Ingredion Inc , FLOWERS FOODS INC are companies with high ratings.

    Return on Equity

    Score 1.90/5
    Glucose Health, Inc. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include
    Glucose Heal... GLUC US$1.4m

    Net Margin

    Score 0.17/5
    Glucose Health, Inc. olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include
    Glucose Heal... GLUC US$1.4m

    Share Buyback

    In Packaged Foods industry , General Mills Inc , Ingredion Inc , FLOWERS FOODS INC are companies with high ratings.

    Leverage

    Score 1.05/5
    Glucose Health, Inc. registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including have achieved high scores.
    Glucose Heal... GLUC US$1.4m

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    SEC financial statements are temporarily unavailable.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Glucose Health, Inc. logo

    Glucose Health, Inc.

    US$0.40

    US$1.4m

    -17.71%

    295.00%